Add 2 More Reports For 20% off

Report Overview

2024

Base Year

2018-2024

Historical Year

2025-2034

Forecast Year

Global Dravet Syndrome Treatment Market Outlook

The global Dravet syndrome treatment market size attained a value of USD 0.40 billion in 2024. The market is likely to expand at a CAGR of 10.10% during the forecast period of 2025-2034 to attain a value of USD 0.94 billion by 2034. The growth of the market is being driven by the rising prevalence of the condition.

dravet syndrome treatment market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Dravet Syndrome Treatment Market: Introduction

Dravet Syndrome, also known as Severe Myoclonic Epilepsy of Infancy (SMEI), is a rare, severe form of epilepsy that starts in infancy. It is a genetic disorder caused by mutations in the SCN1A gene. There is currently no cure for Dravet Syndrome, but there are various treatment options available that aim to manage the symptoms of the disease. The report covers the market for Dravet Syndrome treatment, including drugs and therapies, and provides a detailed analysis of the market size, growth, and trends.

Dravet Syndrome Epidemiology

Dravet Syndrome, also known as Severe Myoclonic Epilepsy of Infancy (SMEI), is a rare genetic disorder that affects approximately one in every 15,700 individuals worldwide. The disease typically begins in infancy, with infants experiencing seizures that are often prolonged and difficult to manage. As the child grows, the seizures may become more frequent and severe, and may be accompanied by cognitive and behavioral problems.

The prevalence of Dravet Syndrome varies by region, but it is estimated to affect approximately one in every 20,000 to 40,000 individuals worldwide. It is more common in males than females, with a male-to-female ratio of approximately 1.5:1.

The treatment options for Dravet Syndrome are focused on managing the symptoms of the disease and improving the quality of life of patients. The primary treatment is medication, specifically anticonvulsants such as clobazam, valproate, and stiripentol. These drugs work by stabilizing the electrical activity in the brain, reducing the frequency and severity of seizures. Benzodiazepines may also be used in combination with anticonvulsants to manage acute seizures.

DRAVET SYNDROME TREATMENT Market Segmentations

The market can be categorised into seizure type, diagnosis type, treatment type, end user, and major region.

dravet syndrome treatment market by segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Breakup by Seizures Type

  • Myoclonic Seizures
  • Atonic Seizures
  • Partial Seizures
  • Absence Seizures
  • Tonic Seizures
  • Photosensitive Seizures
  • Others

Market Breakup by Diagnosis Type

  • Magnetic Resonance Imaging
  • Electroencephalography
  • SCN1 A Testing
  • Others

Market Breakup by Treatment Type

  • Seizure Medications
  • Ketogenic Diet
  • Vagus Nerve Stimulation
  • Others

Market Breakup by End User

  • Pharmaceutical Companies
  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Institutes
  • Others

Market Breakup by Region

  • North America
    • United States of America
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others

dravet syndrome treatment market by region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Dravet Syndrome Treatment Market Scenario

The global Dravet syndrome treatment market is expected to grow at a significant rate during the forecast period of 2025-2034. The increasing prevalence of the disease, rising awareness, and growing investment in research and development activities are the key drivers of the market. North America dominates the market, followed by Europe and Asia Pacific. The leading players in the market are focusing on the development of new drugs and therapies and adopting various strategies to strengthen their position in the market.

North America dominates the Dravet Syndrome treatment market, followed by Europe and Asia Pacific. The high prevalence of Dravet Syndrome in North America, coupled with the favorable reimbursement policies, is driving the growth of the market in the region. Europe is also a significant market for Dravet Syndrome treatment, with the presence of key players and increasing investment in research and development activities. The Asia Pacific region is expected to grow at the highest CAGR during the forecast period, owing to the increasing awareness about the disease and the rising healthcare expenditure in the region.

Key Players in the Global Dravet Syndrome Treatment Market

The report gives an in-depth analysis of the key players involved in the Dravet Syndrome Treatment market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:

  • Biocodex
  • Biscayne Neurotherapeutics (Supernus Pharmaceuticals, Inc.)
  • Cyberonics (LivaNova PLC)
  • Epygenix Therapeutics, Inc.
  • GW Pharmaceuticals (Jazz Pharmaceuticals, Inc.)
  • OPKO Health, Inc.
  • Ovid Therapeutics
  • PTC Therapeutics
  • Encoded Therapeutics, Inc.
  • Zogenix (UCB S.A., Belgium)
  • Takeda Pharmaceutical Company Limited

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2018-2024
Forecast Period 2025-2034
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Seizures Type
  • Diagnosis Type
  • Treatment Type
  • End User
  • Region
Breakup by Seizures Type
  • Myoclonic Seizures
  • Atonic Seizures
  • Partial Seizures
  • Absence Seizures
  • Tonic Seizures
  • Photosensitive Seizures
  • Others
Breakup by Diagnosis Type
  • Magnetic Resonance Imaging
  • Electroencephalography
  • Scn1 A Testing
  • Others
Breakup by Treatment Type
  • Seizure Medications
  • Ketogenic Diet
  • Vagus Nerve Stimulation
  • Others
Breakup by End User
  • Pharmaceutical Companies
  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Institutes
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model
  • Key Demand Indicators 
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends
  • Value Chain Analysis

Supplier Landscape

  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Biocodex
  • Biscayne Neurotherapeutics (Supernus Pharmaceuticals, Inc.)
  • Cyberonics (LivaNova PLC)
  • Epygenix Therapeutics, Inc.
  • GW Pharmaceuticals (Jazz Pharmaceuticals, Inc.)
  • OPKO Health, Inc.
  • Ovid Therapeutics
  • PTC Therapeutics
  • Encoded Therapeutics, Inc.
  • Zogenix (UCB S.A., Belgium)
  • Takeda Pharmaceutical Company Limited

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market attained a value of about USD 0.40 billion in 2024.

The market is likely to expand at a CAGR of 10.10% during the forecast period of 2025-2034 to attain a value of USD 0.94 billion by 2034.

The market is primarily driven by the rising prevalence of chronic disorders, increasing research and developmental activities, robust clinical products pipeline and favouring government initiatives.

North America is anticipated to hold a maximum share of the market during the forecast period.

Based on the seizure type, the market is segmented into myoclonic seizures, atonic seizures, partial seizures, absence seizures, tonic seizures, photosensitive seizures, and others.

Based on the diagnosis type, the market is bifurcated into Magnetic Resonance Imaging (MRI), electroencephalography, Scn1 A testing, and others.

Based on the end users, the market is divided into pharmaceutical companies, hospitals, diagnostic laboratories, academic & research institutes, and others.

The different regions in the market are North America, Europe, Asia Pacific, Latin America and the Middle East and Africa.

The key companies involved in the market are Biocodex, Biscayne Neurotherapeutics (Supernus Pharmaceuticals, Inc.), Cyberonics (LivaNova PLC), Epygenix Therapeutics, Inc., GW Pharmaceuticals (Jazz Pharmaceuticals, Inc.), OPKO Health, Inc., Ovid Therapeutics, PTC Therapeutics, Encoded Therapeutics, Inc., Zogenix (UCB S.A., Belgium), and Takeda Pharmaceutical Company Limited, among others.

Datasheet

10 % Off

USD

3,299

2,969

Single User License

10 % Off

USD

5,499

4,949

Five User License

15 % Off

USD

6,999

5,949

Corporate License

15 % Off

USD

8,199

6,969

Datasheet

One User

USD 3,299

USD 2,969

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 5,499

USD 4,949

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 6,999

USD 5,949

tax inclusive*

  • All Selected Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 8,199

USD 6,969

tax inclusive*

  • All Selected Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124